For much of the history of in-vitro fertilisation (IVF), technological advances have focused overwhelmingly on the egg and the embryo. Advances in ovarian stimulation protocols, time-lapse embryo imaging, genetic testing and cryopreservation have dramatically improved clinical outcomes over the past three decades. However, one biological contributor to reproduction – the sperm – has remained comparatively underexamined.
This imbalance is striking when viewed through a scientific lens. Sperm contributes to half the genetic material to an embryo and growing evidence shows that sperm quality influences not only fertilisation rates but also embryo development, miscarriage risk and potentially long-term health. Despite this, the main laboratory methods used to prepare sperm samples for IVF have remained largely unchanged for more than 25 years.
Recent innovations in sperm separation technology represent a meaningful shift in this landscape and reflect a broader evolution in reproductive medicine. The field is moving toward biologically informed, minimally invasive laboratory techniques designed to better mimic natural selection processes while reducing cellular stress. This shift provides a compelling example of how refinements in laboratory handling can translate into clinically meaningful changes.
In natural conception, sperm selection is an extraordinarily rigorous biological process. From millions of sperm cells released during ejaculation, only a small fraction survive the journey through the female reproductive tract. Those that reach the egg must demonstrate optimal motility, intact DNA and functional competence. IVF laboratory insemination bypasses many of these natural filters particularly when using intracytoplasmic sperm injection (ICSI). Using this process, embryologists select an individual sperm from a heterogeneous population containing sperm with varying levels of DNA integrity, motility, morphology and metabolic health. The central challenge has always been how to isolate the highest-quality sperm while preserving physiological function.
Traditionally, laboratories have relied on density gradient centrifugation and swim-up techniques. These methods separate sperm based on density and motility through high-speed spinning and layered media. While effective at isolating motile sperm, centrifugation can introduce mechanical and oxidative stress. Research has shown that repeated centrifugation may increase reactive oxygen species, which can damage sperm DNA and cellular membranes. DNA fragmentation is particularly significant because it has been linked to reduced embryo viability, lower implantation rates and increased miscarriage risk. This creates a biological paradox in which the very process used to prepare sperm for fertilisation may compromise its reproductive potential.
Microfluidic sperm separation technologies
Instead of selecting sperm based on passive characteristics such as density, microfluidic systems select for functional competence the sperm that successfully migrate tend to demonstrate strong motility, efficient energy metabolism, and intact cellular membranes – qualities that closely align with those required for fertilisation in vivo (inside the body).
From a cellular biology perspective, this approach offers several advantages. Gentle handling reduces oxidative stress and helps preserve genomic integrity. It also minimises variability between laboratory operators because the selection process relies less on manual technique. By allowing sperm to self-select through active movement, these systems more closely mimic physiological conditions within the female reproductive tract. This alignment with natural biological processes reflects a broader trend in reproductive medicine toward reducing artificial manipulation while preserving cellular health.
The most important question for clinicians, however, is whether these biological advantages translate into measurable clinical outcomes. Early data suggests they can. Laboratories that have adopted microfluidic sperm selection methods have reported modest but statistically meaningful increases in fertilisation rates, along with improvements in embryo quality metrics. Here at Adora Fertility we have seen a 2% increase in fertilisation rates since it was introduced. While the numerical changes may appear small, their clinical significance should not be underestimated. IVF outcomes are inherently probabilistic, and many patients require multiple treatment cycles. Even small gains in fertilisation efficiency can influence cumulative pregnancy success over time.
There is also growing evidence that improved sperm selection may have downstream effects beyond fertilisation itself. Studies indicate associations with higher blastocyst formation rates and reduced levels of DNA fragmentation. In certain patient groups, particularly those with elevated sperm DNA fragmentation, recurrent miscarriage, or unexplained infertility, these technologies may provide more than incremental benefit. For these individuals, optimising sperm integrity can directly affect embryo development and implantation potential.
Another important implication of advances in sperm selection technology is conceptual rather than purely technical. Historically, IVF research and treatment have disproportionately focussed on the female partner, reflecting the complexities of ovarian biology and pregnancy physiology. However, male factor infertility contributes to roughly half of infertility cases globally. The emergence of new sperm handling technologies signals a broader recognition of the male contribution as an equally critical determinant of reproductive outcomes.
This shift aligns with expanding scientific understanding of sperm biology. Research increasingly highlights the role of sperm epigenetics, RNA content, and genomic integrity in early embryogenesis. Paternal age effects and environmental influences on sperm DNA are also gaining attention. Collectively, these insights underscore that sperm quality is not simply a matter of count and motility but involves complex molecular and functional characteristics that can influence reproductive success.
Beyond biological and clinical outcomes, new sperm selection technologies also have operational implications for IVF laboratories. Modern embryology labs function within stringent quality management systems where consistency, traceability, and minimisation of variability are essential. Microfluidic separation methods can streamline laboratory workflows by reducing handling steps and standardising preparation processes. Their relatively simple protocols can improve reproducibility across operators and align with broader trends toward automation and quality optimisation in clinical laboratories.
Despite their promise, it is important to evaluate these technologies with scientific caution. Long-term outcome data, particularly regarding cumulative live birth rates, remains limited. Further research is needed to establish cost-effectiveness across different healthcare settings and to determine which patient populations benefit most. Comparative studies between various microfluidic platforms are also still emerging. As with many innovations in reproductive medicine, widespread adoption will depend on robust clinical evidence demonstrating meaningful improvements in patient outcomes.
Viewed in a broader context, advances in sperm selection technology reflect a deeper transformation within IVF. Historically, many laboratory processes prioritised mechanical efficiency rather than biological optimisation. Today, the field is increasingly focussed on techniques that minimise cellular stress, preserve physiological function, and replicate natural reproductive environments as closely as possible. This shift is visible across multiple aspects of IVF, from embryo culture systems to non-invasive viability assessment and artificial intelligence-assisted selection tools.
Although sperm separation technology may not capture headlines in the same way as genetic testing or AI-driven diagnostics, its significance lies in addressing a longstanding gap in reproductive laboratory practice. By refining how sperm are selected and handled, these innovations highlight the importance of the male contribution to fertility and demonstrate how relatively modest technological changes can produce meaningful clinical improvements.
This evolution provides a clear example of translational science in action. Advances grounded in fundamental cellular biology are being translated into practical laboratory tools that improve efficiency, enhance reproductive outcomes, and support a more balanced understanding of human fertility. As IVF continues to evolve, optimising every component of the reproductive process – including those historically overlooked – will remain essential to achieving the best possible outcomes for patients.
Author Bio
Emma Ebinger, Scientific Director at Adora Fertility
Emma Ebinger is an experienced reproductive scientist and embryologist with more than two decades in assisted reproductive technology, specialising in IVF laboratory practice, embryo development, and clinical innovation. She is the Scientific Director at Adora Fertility, where she oversees scientific standards, laboratory advancements, and the translation of emerging reproductive technologies into clinical care. Her work focuses on improving treatment outcomes through evidence-based laboratory techniques, with particular interest in sperm and embryo quality, laboratory optimisation, and the evolving science of human fertility.
